Toripalimab Combined With Concurrent Chemoradiotherapy in Cervical Cancer
Phase 2 Unknown
96 enrolled
Tislelizumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer
Phase 2 Unknown
30 enrolled
MITO CERV 2
Phase 2 Unknown
108 enrolled
Evaluate the Effect of ReSpaceâ„¢ Hydrogel on Reducing Rectal Radiation Dose in Radiotherapy for Cervical Cancer
Phase 2 Unknown
100 enrolled
GCR-05
Phase 2 Unknown
55 enrolled
A Phase II Trial to Evaluate the Efficacy and Safety of QL1706 in Patients With Cervical Cancer
Phase 2 Unknown
150 enrolled
Pembrolizumab Plus Olaparib in Patients With Recurrent Cervical Cancer
Phase 2 Unknown
28 enrolled
Safety and Efficacy Study of First-line Treatment With QL1706 Plus Chemotherapy With or Without Bevacizumab in Women With Recurrent, or Metastatic Cervical Cancer
Phase 2 Unknown
60 enrolled
A Clinical Study to Explore the Efficacy and Safety of Tislelizumab in Combination With Bevacizumab and Chemotherapy in Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Phase 2 Unknown
49 enrolled
A Phase II Study of Serplulimab Plus Bevacizumab in Combination With Chemotherapy in 1L Treatment of Untreated Recurrent or Metastatic Cervical Cancer
Phase 2 Unknown
48 enrolled
Famitinib Plus Anti-PD1 Therapy for Advanced Urinary System Tumor, Advanced Gynecological Tumors
Phase 2 Unknown
265 enrolled
Clinical Study on the Safety, Pharmacokinetics, and Efficacy of ScTIL (Genetically Modified Tumor Infiltrating Lymphocytes) in the Treatment of Gynecological Malignancies
Phase 2 Unknown
30 enrolled
Effect of Compound Kushen Injection Combined With Pabolizumab in the Treatment of Cervical Adenocarcinoma
Phase 2 Unknown
42 enrolled
Immunotherapy for Recurrent Cervical Cancer Refractory to Platinum-based Chemotherapy: Multi-Center Trial
Phase 2 Unknown
122 enrolled
H101 Combined With Camrelizumab for Recurrent Cervical Cancer
Phase 2 Unknown
55 enrolled
A Study of Sintilimab Combined With Concurrent Chemoradiation Therapy in Locally Advanced Cervical Cancer
Phase 2 Unknown
20 enrolled
A Study of Carilizumab Combined With Concurrent Chemoradiotherapy
Phase 2 Unknown
46 enrolled
Study of the SG001 Injection for Patients With Relapsed or Metastatic Uterine Cervical Cancer
Phase 2 Unknown
104 enrolled
First-line Treatment With Camrelizumab + Apatinib Versus Chemotherapy + Bevacizumab in Advanced Cervical Cancer
Phase 2 Unknown
172 enrolled
A Study of Camrelizumab Combined With Concurrent Chemoradiation in Patients With Cervical Cancer
Phase 2 Unknown
46 enrolled
Toripalimab Combined With Chemotherapy and Bevacizumab as First-Line Treatment in Patients With Advanced Cervical Cancer
Phase 2 Unknown
35 enrolled
A Study of TQ-B3525 Tablets in Subjects With PIK3CA and/or PIK3R1/2 Gene-altered Recurrent/Metastatic Advanced Gynecologic Tumors
Phase 2 Unknown
90 enrolled
CQGOG0101
Phase 2 Unknown
38 enrolled
A Study in Recurrent or Metastatic Cervical Cancer Patients With PD-L1 Positive
Phase 2 Unknown
80 enrolled
Camrelizumab Combined With Chemotherapy for Recurrent or Advanced Cervical Neuroendocrine Carcinomas
Phase 2 Unknown
20 enrolled
A Study of TQB2450 Injection in Subjects With PD-L1 Positive Recurrent or Metastatic Cervical Cancer
Phase 2 Unknown
80 enrolled
Selective Pelvic Lymphadenectomy for IB-IIA Cervical Cancer
Phase 2 Unknown
200 enrolled
Safety and Efficacy of p53 Gene Therapy Combined With Immune Checkpoint Inhibitors in Solid Tumors.
Phase 2 Unknown
40 enrolled
CCRT Combined With Endostar for the Treatment of Locally Advanced Cervical Cancer
Phase 2 Unknown
82 enrolled
V3-Cervix
Phase 2 Unknown
20 enrolled
CC
Phase 2 Unknown
89 enrolled
Efficacy and Safety of BCD-100 (Anti-PD-1) in Combination With Platinum-Based Chemotherapy and Bevacizumab in Patients With Recurrent, Persistent or Metastatic Cervical Cancer (CAESURA)
Phase 2 Unknown
49 enrolled
ChESS
Phase 2 Unknown
120 enrolled
Study of Nimotuzumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer
Phase 2 Unknown
100 enrolled
Apatinib Treating Patients With Advanced Cervical Cancer After Radiotherapy and First-line Chemotherapy.
Phase 2 Unknown
69 enrolled
Pelvic External Combined With 252-Cf Neutron Intracavitary Radiotherapy With or Without Platinum in Treating Advanced Cervical Cancer
Phase 2 Unknown
200 enrolled
Phase II Clinical Trial of Concurrent Chemoradiotherapy Combined Nimotuzumab for Stage IIB-IVA Cervical Cancer
Phase 2 Unknown
60 enrolled
TGOG1005
Phase 2 Unknown
44 enrolled
Preoperative Chemoradiotherapy Combined With Nimotuzumab for Cervical Cancer
Phase 2 Unknown
40 enrolled
Paclitaxel and Carboplatin Followed by Cisplatin and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer
Phase 2 Unknown
50 enrolled
Early Detection of Breast Cancer and Cervical Cancer in Women in India
Phase 2 Unknown
151,538 enrolled
External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases
Phase 2 Unknown
60 enrolled
Cisplatin Combined With Radiation Therapy and Hyperthermia in Treating Patients With Stage II, Stage III, or Stage IV Cervical Cancer
Phase 2 Unknown
CSAPPPCC
Phase 2 Unknown
30 enrolled
Concurrent Chemoradiotherapy for Cervical Cancer in Elderly Women
Phase 2 Unknown
45 enrolled
Adjuvant Chemotherapy in Patients With Lymph Node Metastasis After Radical Surgery in Cervical Cancer
Phase 2 Unknown
69 enrolled
Cetuximab, Cisplatin, and Radiotherapy in Women With Locally Advanced Cervical Carcinoma
Phase 2 Unknown
30 enrolled
Panitumumab, Cisplatin, and Pelvic Radiation Therapy in Treating Patients With Stage IB, Stage II, or Stage III Cervical Cancer
Phase 2 Unknown
50 enrolled
Tomotherapy in Postsurgery Recurrent Carcinoma Cervix
Phase 2 Unknown
90 enrolled
Chemotherapy With Whole Body Hyperthermia to Treat Resistant Breast, Endometrial, Cervical and Ovarian Cancers
Phase 2 Unknown
24 enrolled